SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Khris Smith who wrote (11257)5/14/2012 1:31:53 PM
From: LurkeyTurkey  Read Replies (2) | Respond to of 13111
 
Read today's Blog. Our old friend points out that the rules governing the minimum share price necessary to get listed on Nasdaq have very recently been revised to allow listing (under certain financial circumstances) if that share price can stay at $2 or above for 5 days. With one piece of really good news, that's an achievable target for PVCT. And THAT is the reason for the run-up today.



To: Khris Smith who wrote (11257)5/14/2012 1:38:15 PM
From: NTTG  Respond to of 13111
 
Agreed..could reflect pent up frustration over bad management decisions in the past, an independent board might be seen by some as a breath of fresh air if they have real teeth.

.....or it could just be simple confusion over "planned filing for NASDAQ" and the recent string of company announcement about realignment of the NASDAQ Biotech Index funds.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News